Skip to main content

VITAMINA D EN LA HIPERTENSION PULMONAR

SAF2016-77222-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Activation of Kv7 channels as a novel mechanism for NO/cGMP‐induced pulmonary vasodilation

  • Mondéjar‐Parreño, Gema
  • Moral‐Sanz, Javier
  • Barreira, Bianca
  • Cruz, Alicia de la
  • González, Teresa
  • Callejo, Maria
  • Esquivel‐Ruiz, Sergio
  • Morales‐Cano, Daniel
  • Moreno Capellán, Laura
  • Valenzuela, Carmen
  • Pérez-Vizcaíno, Francisco
  • Cogolludo, Angel
[Background and Purpose]: The NO/cGMP pathway represents a major physiological signalling controlling tone in pulmonary arteries (PA), and drugs activating this pathway are used to treat pulmonary arterial hypertension. Kv channels expressed in PA smooth muscle cells (PASMCs) are key determinants of vascular tone. We aimed to analyse the contribution of Kv1.5 and Kv7 channels in the electrophysiological and vasodilating effects evoked by NO donors and the GC stimulator riociguat in PA., [Experimental Approach]: Kv currents were recorded in isolated rat PASMCs using the patch‐clamp technique. Vascular reactivity was assessed in a wire myograph., [Key Results]: The NO donors diethylamine NONOate diethylammonium (DEA‐NO) and sodium nitroprusside hyperpolarized the membrane potential and induced a bimodal effect on Kv currents (augmenting the current between −40 and −10 mV and decreasing it at more depolarized potentials). The hyperpolarization and the enhancement of the current were suppressed by Kv7 channel inhibitors and by the GC inhibitor ODQ but preserved when Kv1.5 channels were inhibited. Additionally, DEA‐NO enhanced Kv7.5 currents in COS7 cells expressing the KCNQ5 gene. Riociguat increased Kv currents at all potentials ≥−40 mV and induced membrane hyperpolarization. Both effects were prevented by Kv7 inhibition. Likewise, PA relaxation induced by NO donors and riociguat was attenuated by Kv7 inhibitors., [Conclusions and Implications]: NO donors and riociguat enhance Kv7 currents, leading to PASMC hyperpolarization. This mechanism contributes to NO/cGMP‐induced PA vasodilation. Our study identifies Kv7 channels as a novel mechanism of action of vasodilator drugs used in the treatment of pulmonary arterial hypertension., This work was funded by Ministerio de Economía y Competitividad grants (SAF2016‐77222R to F.P.‐V. and A.C. and SAF2016‐75021‐R to C.V. and T.G.), the Cardiovascular Medical Research and Education Fund (A.C.), Fundación Contra la Hipertensión Pulmonar‐EMPATHY, Comunidad de Madrid (B2017/BMD‐3727 to A.C. and L.M.), and Instituto de Salud Carlos III (PI15/01100 to L.M. and CB/11/00222 to C.V.) with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER). G.M.‐P., M.C., and S.E.‐R. are supported by CIBERES, Universidad Complutense and FPU grants., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Elevated pulmonary arterial pressure in Zucker diabetic fatty rats

  • Morales-Cano, Daniel
  • Callejo, Maria
  • Barreira, Bianca
  • Mondejar-Parreño, Gema
  • Esquivel-Ruiz, Sergio
  • Ramos, Sonia
  • Martín, M. Ángeles
  • Cogolludo, Angel
  • Moreno Capellán, Laura
  • Pérez-Vizcaíno, Francisco
Diabetes is a very strong predictor of chronic systemic vascular diseases and acute cardiovascular events. Recently, associations between metabolic disorders and pulmonary hypertension have also been reported in both humans and animal models. In order to get some further insight into the relationship of pulmonary hypertension with obesity, insulin resistance and hyperglycemia, herein we have used the Zucker diabetic fatty rats (ZDF/clr-lepr fa) at 20 weeks fed a standard diet and compared to their lean Zucker littermates (ZL). ZDF rats were obese, had elevated plasma glucose levels and insulin resistance, i.e. a clinically relevant model of type 2 diabetes. They presented elevated systolic, diastolic and mean pulmonary arterial pressures and a parallel increase in the Fulton index. Systemic arterial pressures were also increased but the left ventricle plus septum weight was similar in both groups and the heart rate was reduced. Wall media thickening was observed in the small pulmonary arteries from the ZDF rats. Isolated pulmonary arteries mounted in a wire myograph showed similar vasoconstrictor responses to phenylephrine and 5-HT and similar responses to the endothelium-dependent vasodilator acetylcholine. However, the iNOS inhibitor 1400W enhanced the vasoconstrictor responses in ZDF but not in ZL rats. The protein expression of eNOS and iNOS was not significantly different in the lungs of the two groups. The lung expression of Bmpr2 mRNA was downregulated. However, the mRNA expression of Kcna5, Kcnk3, Kcnq1, Kcnq4 or Kcnq5, which encode for the potassium channels Kv1.5, TASK-1, Kv7.1, Kv7.4 and Kv7.5, respectively, was similar in ZL and ZDF rats. In conclusion, ZDF rats show increased pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arterial medial thickening and downregulated lung Bmpr2 despite leptin resistance. These changes were mild but are consistent with the view that diabetes is a risk factor for pulmonary hypertension., This study was supported by grants from Ministerio de Economía y Competitividad (Mineco, https://sede.micinn.gob.es SAF2016-77222-R to FPV and AC and AGL2015–67087-R to SR and MAM), Instituto de Salud Carlos III (www.isciii.es, PI15/01100 to LM), with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER). M.C., G.M-P. and S.E-R. are funded by Universidad Complutense (www.ucm.es) and Ciberes (www.Ciberes.org) grant with funds from Fundacion Contra la Hipertension Pulmonar (Enpathy, www.fchp.es) and a FPU grant from Ministerio de Educacion (www.mecd.gob.es), respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dietary cocoa prevents aortic remodeling and vascular oxidative stress in diabetic rats

  • Álvarez-Cilleros, David
  • López-Oliva, Elvira
  • Morales-Cano, Daniel
  • Barreira, Bianca
  • Pérez-Vizcaíno, Francisco
  • Goya, Luis
  • Ramos, Sonia
  • Martín, M. Ángeles
[Scope]: The aim of the present study is to investigate the potential protective effect of a cocoa‐rich diet on functional and structural vascular alterations in diabetes and the mechanism involved., [Methods and results]: Male Zucker diabetic fatty (ZDF) rats are fed on a standard (ZDF‐C) or cocoa‐rich diet (ZDF‐Co) from week 10 to 20 of life. Diabetic ZDF‐C rats showed increased blood pressure and enhanced aortic stiffness, as demonstrated by the increased pulse pressure and the augmented aortic medial thickness with loss and disruption of elastic fibres. Interestingly, cocoa intake strongly avoided all these adverse effects and reduced aortic oxidative stress. Mechanistically, cocoa diet prevented sirtuin‐1 (SIRT‐1) depletion and increased NADPH oxidases (NOXs) and reactive oxygen species production as well as reduced active nuclear factor E2 related factor 2 (Nrf2) and their antioxidant products., [Conclusion]: The results demonstrate for the first time that a cocoa‐rich diet strongly prevents aortic stiffening and remodeling in diabetic animals and avoids aortic oxidative stress. It is suggested that this effect could be mediated via its effects on SIRT‐1, NOXs, and Nrf2., This work was supported by grants AGL 2015–67087‐R and SAF2016‐77222‐R (MINECO/FEDER, UE) from the Spanish Ministry of Science and Innovation (MINECO). D.Á.‐C. is a FPI fellow from the predoctoral program of MINECO (BES‐2016‐076721)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Na+ controls hypoxic signalling by the mitochondrial respiratory chain

  • Hernansanz-Agustín, Pablo
  • Choya-Foces, Carmen
  • Carregal-Romero, Susana
  • Ramos, Elena
  • Oliva, Tamara
  • Villa-Piña, Tamara
  • Moreno Capellán, Laura
  • Izquierdo-Álvarez, Alicia
  • Cabrera-García, J. Daniel
  • Cortés, Ana
  • Lechuga-Vieco, Ana V.
  • Jadiya, Pooja
  • Navarro, Elena
  • Parada, Esther
  • Palomino-Antolín, Alejandra
  • Tello, Daniel
  • Acín-Pérez, Rebeca
  • Rodríguez-Aguilera, Juan Carlos
  • Navas, Plácido
  • Cogolludo, Angel
  • López-Montero, Iván
  • Martínez-del-Pozo, Álvaro
  • Egea, Javier
  • López, Manuela G.
  • Elrod, John W.
  • Ruiz-Cabello, Jesús
  • Bogdanova, Anna
  • Enríquez, José Antonio
  • Martínez-Ruiz, Antonio
All metazoans depend on the consumption of O2 by the mitochondrial oxidative phosphorylation system (OXPHOS) to produce energy. In addition, the OXPHOS uses O2 to produce reactive oxygen species that can drive cell adaptations1,2,3,4, a phenomenon that occurs in hypoxia4,5,6,7,8 and whose precise mechanism remains unknown. Ca2+ is the best known ion that acts as a second messenger9, yet the role ascribed to Na+ is to serve as a mere mediator of membrane potential10. Here we show that Na+ acts as a second messenger that regulates OXPHOS function and the production of reactive oxygen species by modulating the fluidity of the inner mitochondrial membrane. A conformational shift in mitochondrial complex I during acute hypoxia11 drives acidification of the matrix and the release of free Ca2+ from calcium phosphate (CaP) precipitates. The concomitant activation of the mitochondrial Na+/Ca2+ exchanger promotes the import of Na+ into the matrix. Na+ interacts with phospholipids, reducing inner mitochondrial membrane fluidity and the mobility of free ubiquinone between complex II and complex III, but not inside supercomplexes. As a consequence, superoxide is produced at complex III. The inhibition of Na+ import through the Na+/Ca2+ exchanger is sufficient to block this pathway, preventing adaptation to hypoxia. These results reveal that Na+ controls OXPHOS function and redox signalling through an unexpected interaction with phospholipids, with profound consequences for cellular metabolism., This research has been financed by Spanish Government grants (ISCIII and AEI agencies, partially funded by the European Union FEDER/ERDF) CSD2007-00020 (RosasNet, Consolider-Ingenio 2010 programme to A.M.-R. and J.A.E.); CP07/00143, PS09/00101, PI12/00875, PI15/00107 and RTI2018-094203-B-I00 (to A.M.-R.); CP12/03304 and PI15/01100 (to L.M.); CP14/00008, CPII19/00005 and PI16/00735 (to J.E.); SAF2016-77222-R (to A. Cogolludo); PI17/01286 (to P.N.); SAF2015-65633-R, RTI2018-099357-B-I00 and CB16/10/00282 (to J.A.E.); RTI2018-095793-B-I00 (to M.G.L.); and SAF2017-84494-2-R (to J.R.-C.), by the European Union (ITN GA317433 to J.A.E. and MC-CIG GA304217 to R.A.-P.), by grants from the Comunidad de Madrid B2017/BMD-3727 (to A. Cogolludo) and B2017/BMD-3827 (to M.G.L.), by a grant from the Fundación Domingo Martínez (to M.G.L. and A.M.-R.), by the Human Frontier Science Program grant HFSP-RGP0016/2018 (to J.A.E.), by grants from the Fundación BBVA (to R.A.-P. and J.R.-C.), by the UCM-Banco Santander grant PR75/18-21561 (to A.M.-d.-P.), by the Programa Red Guipuzcoana de Ciencia, Tecnología e Información 2018-CIEN-000058-01 (to J.R.-C.) and from the Basque Government under the ELKARTEK Program (grant no. KK-2019/bmG19 to J.R.-C.), by the Swiss National Science Foundation (SNF) grant 310030_124970/1 (to A.B.), by a travel grant from the IIS-IP (to P.H.-A.) and by the COST actions TD0901 (HypoxiaNet) and BM1203 (EU-ROS). The CNIC is supported by the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (Spanish Government award SEV-2015-0505). CIC biomaGUNE is supported by the María de Maeztu Units of Excellence Program from the Spanish Government (MDM-2017-0720). P.H.-A. was a recipient of a predoctoral FPU fellowship from the Spanish Government. E.N. is a recipient of a predoctoral FPI fellowship from the Universidad Autónoma de Madrid (UAM). A.M.-R., L.M. and J.E. are supported by the I3SNS or ‘Miguel Servet’ programmes (ISCIII, Spanish Government; partially funded by the FEDER/ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Cocoa diet prevents aortic stiffening and remodelling in type 2 diabetic rats via SIRT-1/NOX-4 mechanisms

  • Martín, M. Ángeles
  • Álvarez-Cilleros, David
  • López-Oliva, Elvira
  • Morales-Cano, Daniel
  • Barreira, Bianca
  • Pérez-Vizcaíno, Francisco
  • Goya, Luis
  • Ramos, Sonia
Trabajo presentado al 55th European Association for the Study of Diabetes (EASD) Annual Meeting., Grant AGL2015-67087-R and SAF2016-77222-R and BES-2016-076721., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Dietary Cocoa Prevents Aortic Remodeling and Vascular Oxidative Stress in Diabetic Rats

  • Álvarez Cilleros, David
  • López-Oliva Muñoz, María Elvira
  • Morales Cano, Daniel
  • Barreira Barba, Bianca
  • Pérez Vizcaíno, Francisco
  • Goya, Luis
  • Ramos, Sonia
  • Martín, María Ángeles
Scope The aim of the present study is to investigate the potential protective effect of a cocoa‐rich diet on functional and structural vascular alterations in diabetes and the mechanism involved. Methods and results Male Zucker diabetic fatty (ZDF) rats are fed on a standard (ZDF‐C) or cocoa‐rich diet (ZDF‐Co) from week 10 to 20 of life. Diabetic ZDF‐C rats showed increased blood pressure and enhanced aortic stiffness, as demonstrated by the increased pulse pressure and the augmented aortic medial thickness with loss and disruption of elastic fibres. Interestingly, cocoa intake strongly avoided all these adverse effects and reduced aortic oxidative stress. Mechanistically, cocoa diet prevented sirtuin‐1 (SIRT‐1) depletion and increased NADPH oxidases (NOXs) and reactive oxygen species production as well as reduced active nuclear factor E2 related factor 2 (Nrf2) and their antioxidant products. Conclusion The results demonstrate for the first time that a cocoa‐rich diet strongly prevents aortic stiffening and remodeling in diabetic animals and avoids aortic oxidative stress. It is suggested that this effect could be mediated via its effects on SIRT‐1, NOXs, and Nrf2.